Sjogren's Syndrome Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been formally diagnosed with primary Sjögren's syndrome
- You are over 18 years old
- You have not received biologic medications or intravenous immunoglobulin therapy in the 6 months before the study starts
If joining the main study group (Arm 1):
- You have symptoms suggesting damage to small nerve fibres — such as reduced ability to feel heat or pain, problems with automatic body functions (like sweating or heart rate), or nerve pain scoring 4 or above on a specific pain questionnaire
- AND you also have at least one abnormal test result, such as nerve function tests (measuring temperature/pain sensitivity or sweat responses) OR a skin biopsy showing reduced nerve fibre density
If joining the control group (Arm 2):
- You have Sjögren's syndrome but show no signs of nerve damage (either small or large nerve fibres)
Who may not be able to join:
- You have another known condition that can cause nerve damage, such as diabetes, alcoholism, HIV, coeliac disease, sarcoidosis, Guillain-Barré syndrome, certain drug or toxic exposures, or specific inherited conditions affecting the nerves (confirm with trial site)
- You have symptoms that suggest small nerve fibre damage (such as reduced heat/pain sensation, automatic body function problems, or significant nerve pain), but all your diagnostic tests — including nerve function tests and skin biopsy — have come back normal
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Damien SÈNE, Assistance Publique - Hôpitaux de Paris
Phone: +33149956380
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Measure of quality of life impairment by SF 36 scale
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.